RecruitingNot ApplicableNCT07506018

MucoLock™ for Treatment of Stomatitis

A Phase II Open-Label Trial of MucoLock™ Oral Rinse for the Treatment of Stomatitis Characterized by Oral Dysesthesia


Sponsor

Baptist Health South Florida

Enrollment

25 participants

Start Date

Apr 15, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this research is to test how well people can tolerate MucoLock™ as a treatment for mouth pain or burning sensation and how well it works to reduce mouth pain or burning sensation. Study participants will be asked to use MucoLock™ topical solution as a "swish and spit" solution (similar to mouthwash) three times per day for 5 minutes each time, for 28 days.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called MucoLock Oral Gel for people with burning mouth, oral dysesthesia, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEMucoLock Oral Gel

15 mL, oral rinse for 5 minutes and spit (do not swallow), 3 times per day, for 28 days


Locations(1)

Miami Cancer Institute at Baptist Health, Inc.

Miami, Florida, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07506018


Related Trials